

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neuronal action potential propagation (GO:0019227) | 6.16432046 |
| 2 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.52463120 |
| 3 | positive regulation by symbiont of host defense response (GO:0052509) | 5.43567483 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 5.43567483 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.43567483 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.43567483 |
| 7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.43567483 |
| 8 | modulation by symbiont of host immune response (GO:0052553) | 5.43567483 |
| 9 | detection of molecule of bacterial origin (GO:0032490) | 5.36082055 |
| 10 | presynaptic membrane assembly (GO:0097105) | 5.34827419 |
| 11 | vocalization behavior (GO:0071625) | 5.16572902 |
| 12 | macrophage activation involved in immune response (GO:0002281) | 5.13505352 |
| 13 | neuron cell-cell adhesion (GO:0007158) | 5.06120826 |
| 14 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.03990148 |
| 15 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.01903163 |
| 16 | protein localization to synapse (GO:0035418) | 4.95039181 |
| 17 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.88322652 |
| 18 | response to peptidoglycan (GO:0032494) | 4.78358955 |
| 19 | presynaptic membrane organization (GO:0097090) | 4.74864572 |
| 20 | postsynaptic membrane organization (GO:0001941) | 4.59617531 |
| 21 | glutamate receptor signaling pathway (GO:0007215) | 4.52589728 |
| 22 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.49485780 |
| 23 | synaptic vesicle exocytosis (GO:0016079) | 4.48430843 |
| 24 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.48077014 |
| 25 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.47907915 |
| 26 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.42614430 |
| 27 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.41040386 |
| 28 | microglial cell activation (GO:0001774) | 4.35127579 |
| 29 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.33902818 |
| 30 | neutrophil activation involved in immune response (GO:0002283) | 4.31746957 |
| 31 | negative regulation of interleukin-12 production (GO:0032695) | 4.30994194 |
| 32 | detection of external biotic stimulus (GO:0098581) | 4.23867839 |
| 33 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.22805406 |
| 34 | detection of other organism (GO:0098543) | 4.17969874 |
| 35 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.17343995 |
| 36 | macrophage activation (GO:0042116) | 4.04703342 |
| 37 | synaptic transmission, glutamatergic (GO:0035249) | 3.98612307 |
| 38 | cellular extravasation (GO:0045123) | 3.94983010 |
| 39 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.93640126 |
| 40 | neuron-neuron synaptic transmission (GO:0007270) | 3.92046674 |
| 41 | gamma-aminobutyric acid transport (GO:0015812) | 3.91715421 |
| 42 | locomotory exploration behavior (GO:0035641) | 3.90969092 |
| 43 | positive regulation of membrane potential (GO:0045838) | 3.90542445 |
| 44 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.82228678 |
| 45 | response to host immune response (GO:0052572) | 3.82228678 |
| 46 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.76712044 |
| 47 | long-term memory (GO:0007616) | 3.73360606 |
| 48 | detection of biotic stimulus (GO:0009595) | 3.73090049 |
| 49 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.70761271 |
| 50 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.70453746 |
| 51 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.69950671 |
| 52 | regulation of postsynaptic membrane potential (GO:0060078) | 3.66782544 |
| 53 | glutamate secretion (GO:0014047) | 3.64588163 |
| 54 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.62296212 |
| 55 | transmission of nerve impulse (GO:0019226) | 3.58088640 |
| 56 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.58012727 |
| 57 | response to host (GO:0075136) | 3.58012727 |
| 58 | response to host defenses (GO:0052200) | 3.58012727 |
| 59 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.55955132 |
| 60 | synaptic vesicle maturation (GO:0016188) | 3.52992547 |
| 61 | detection of bacterium (GO:0016045) | 3.52019403 |
| 62 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.51963818 |
| 63 | neuron recognition (GO:0008038) | 3.51050881 |
| 64 | regulation of gamma-delta T cell activation (GO:0046643) | 3.50597122 |
| 65 | exploration behavior (GO:0035640) | 3.48858284 |
| 66 | neurotransmitter secretion (GO:0007269) | 3.45051161 |
| 67 | myeloid cell activation involved in immune response (GO:0002275) | 3.42620442 |
| 68 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.42208532 |
| 69 | regulation of protein kinase A signaling (GO:0010738) | 3.41768736 |
| 70 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.40945622 |
| 71 | regulation of synaptic vesicle transport (GO:1902803) | 3.40088374 |
| 72 | regulation of vesicle fusion (GO:0031338) | 3.39201252 |
| 73 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.36042015 |
| 74 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.35934963 |
| 75 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.35524945 |
| 76 | neutrophil mediated immunity (GO:0002446) | 3.33589041 |
| 77 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.32894605 |
| 78 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.32530821 |
| 79 | positive regulation of macrophage cytokine production (GO:0060907) | 3.31613179 |
| 80 | positive regulation of dendritic spine development (GO:0060999) | 3.31511511 |
| 81 | neutrophil activation (GO:0042119) | 3.29013376 |
| 82 | short-term memory (GO:0007614) | 3.26918443 |
| 83 | response to muramyl dipeptide (GO:0032495) | 3.26762580 |
| 84 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.25802349 |
| 85 | regulation of mast cell degranulation (GO:0043304) | 3.24029506 |
| 86 | regulation of macrophage cytokine production (GO:0010935) | 3.23307551 |
| 87 | positive regulation of mast cell activation (GO:0033005) | 3.22588056 |
| 88 | granulocyte activation (GO:0036230) | 3.18918949 |
| 89 | response to histamine (GO:0034776) | 3.18548226 |
| 90 | membrane depolarization (GO:0051899) | 3.17687038 |
| 91 | dendritic spine morphogenesis (GO:0060997) | 3.17639320 |
| 92 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.17281470 |
| 93 | righting reflex (GO:0060013) | 3.16989693 |
| 94 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.15219669 |
| 95 | startle response (GO:0001964) | 3.14265455 |
| 96 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.13510838 |
| 97 | regulation of leukocyte degranulation (GO:0043300) | 3.12791015 |
| 98 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.12130149 |
| 99 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.11780115 |
| 100 | neurotransmitter transport (GO:0006836) | 3.11164606 |
| 101 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.10173192 |
| 102 | positive regulation of synapse assembly (GO:0051965) | 3.09763359 |
| 103 | negative regulation of T cell mediated immunity (GO:0002710) | 3.09063622 |
| 104 | synapse assembly (GO:0007416) | 3.08669568 |
| 105 | leukocyte aggregation (GO:0070486) | 3.08086638 |
| 106 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.07831558 |
| 107 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.07640851 |
| 108 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.06004646 |
| 109 | regulation of dendritic spine development (GO:0060998) | 3.05667786 |
| 110 | T-helper 1 type immune response (GO:0042088) | 3.05305711 |
| 111 | germinal center formation (GO:0002467) | 3.04962252 |
| 112 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.04929954 |
| 113 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.04619122 |
| 114 | negative regulation of interleukin-17 production (GO:0032700) | 3.03855730 |
| 115 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.03003569 |
| 116 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.00964300 |
| 117 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.99812644 |
| 118 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.98768067 |
| 119 | positive regulation of mast cell degranulation (GO:0043306) | 2.98768067 |
| 120 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.98226166 |
| 121 | positive regulation of interferon-alpha production (GO:0032727) | 2.97773889 |
| 122 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.97703078 |
| 123 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.97179757 |
| 124 | regulation of interferon-alpha production (GO:0032647) | 2.96801050 |
| 125 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.96350084 |
| 126 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.96281016 |
| 127 | regulation of synaptic plasticity (GO:0048167) | 2.95415177 |
| 128 | immunoglobulin mediated immune response (GO:0016064) | 2.95224525 |
| 129 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.94774103 |
| 130 | myeloid leukocyte mediated immunity (GO:0002444) | 2.92668531 |
| 131 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.90392952 |
| 132 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.90356974 |
| 133 | adult walking behavior (GO:0007628) | 2.89880828 |
| 134 | learning (GO:0007612) | 2.89195584 |
| 135 | long-term synaptic potentiation (GO:0060291) | 2.88127192 |
| 136 | regulation of glutamate secretion (GO:0014048) | 2.86197242 |
| 137 | respiratory burst (GO:0045730) | 2.85360243 |
| 138 | regulation of mast cell activation (GO:0033003) | 2.85121036 |
| 139 | regulation of neurotransmitter secretion (GO:0046928) | 2.83907988 |
| 140 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.82619035 |
| 141 | regulation of neurotransmitter levels (GO:0001505) | 2.82013900 |
| 142 | cerebellar granule cell differentiation (GO:0021707) | 2.81837383 |
| 143 | neuron remodeling (GO:0016322) | 2.81068677 |
| 144 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.80961101 |
| 145 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.80642535 |
| 146 | negative regulation of type 2 immune response (GO:0002829) | 2.79911941 |
| 147 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.78285732 |
| 148 | regulation of regulated secretory pathway (GO:1903305) | 2.78080570 |
| 149 | B cell receptor signaling pathway (GO:0050853) | 2.77957090 |
| 150 | defense response to protozoan (GO:0042832) | 2.77866184 |
| 151 | neuromuscular process controlling posture (GO:0050884) | 2.77849708 |
| 152 | axonal fasciculation (GO:0007413) | 2.77201465 |
| 153 | positive regulation of leukocyte degranulation (GO:0043302) | 2.73774139 |
| 154 | membrane hyperpolarization (GO:0060081) | 2.73701542 |
| 155 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.73331337 |
| 156 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.72397333 |
| 157 | mating behavior (GO:0007617) | 2.72124120 |
| 158 | detection of calcium ion (GO:0005513) | 2.72097934 |
| 159 | serotonin receptor signaling pathway (GO:0007210) | 2.71394673 |
| 160 | L-amino acid import (GO:0043092) | 2.71174952 |
| 161 | behavioral response to cocaine (GO:0048148) | 2.69532724 |
| 162 | positive regulation of neurotransmitter transport (GO:0051590) | 2.69361662 |
| 163 | membrane assembly (GO:0071709) | 2.68861903 |
| 164 | layer formation in cerebral cortex (GO:0021819) | 2.68504490 |
| 165 | myeloid leukocyte activation (GO:0002274) | 2.66966800 |
| 166 | regulation of beta-amyloid formation (GO:1902003) | 2.66862025 |
| 167 | synaptic transmission (GO:0007268) | 2.66708879 |
| 168 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.66644472 |
| 169 | cellular response to type I interferon (GO:0071357) | 2.66398485 |
| 170 | type I interferon signaling pathway (GO:0060337) | 2.66398485 |
| 171 | behavioral fear response (GO:0001662) | 2.66326316 |
| 172 | behavioral defense response (GO:0002209) | 2.66326316 |
| 173 | response to interleukin-15 (GO:0070672) | 2.66051481 |
| 174 | social behavior (GO:0035176) | 2.64906956 |
| 175 | intraspecies interaction between organisms (GO:0051703) | 2.64906956 |
| 176 | regulation of synapse structural plasticity (GO:0051823) | 2.64539529 |
| 177 | response to type I interferon (GO:0034340) | 2.63943786 |
| 178 | regulation of synapse assembly (GO:0051963) | 2.63721420 |
| 179 | regulation of respiratory system process (GO:0044065) | 2.62929388 |
| 180 | mechanosensory behavior (GO:0007638) | 2.62676547 |
| 181 | regulation of synaptic transmission (GO:0050804) | 2.60865527 |
| 182 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.60106190 |
| 183 | fear response (GO:0042596) | 2.59810877 |
| 184 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.59405995 |
| 185 | negative regulation of cell killing (GO:0031342) | 2.59405995 |
| 186 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.59118379 |
| 187 | neutrophil chemotaxis (GO:0030593) | 2.57400270 |
| 188 | protein localization to endosome (GO:0036010) | 2.55481771 |
| 189 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.55451498 |
| 190 | regulation of type 2 immune response (GO:0002828) | 2.54699018 |
| 191 | response to protozoan (GO:0001562) | 2.54290399 |
| 192 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.54214997 |
| 193 | regulation of tolerance induction (GO:0002643) | 2.54070376 |
| 194 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.51958286 |
| 195 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.51669850 |
| 196 | neutrophil migration (GO:1990266) | 2.50556430 |
| 197 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.49967892 |
| 198 | positive regulation of type 2 immune response (GO:0002830) | 2.49605705 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.35422284 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.38792720 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.06150713 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.83411287 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.70070735 |
| 6 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.64590448 |
| 7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.38614441 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.36028010 |
| 9 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.29493352 |
| 10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.28544215 |
| 11 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.12377700 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.08520297 |
| 13 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.03180002 |
| 14 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.00586535 |
| 15 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.93144737 |
| 16 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.89716310 |
| 17 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.84829335 |
| 18 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.75960681 |
| 19 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.73822573 |
| 20 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.70616425 |
| 21 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.63154437 |
| 22 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.63043267 |
| 23 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.63043267 |
| 24 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.60025328 |
| 25 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.56439165 |
| 26 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.51817817 |
| 27 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.45374680 |
| 28 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.37175262 |
| 29 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.35486968 |
| 30 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.33098954 |
| 31 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.32692375 |
| 32 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.29596284 |
| 33 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.24266108 |
| 34 | SPI1_23127762_ChIP-Seq_K562_Human | 2.23445846 |
| 35 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.18788291 |
| 36 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.15671883 |
| 37 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.14828792 |
| 38 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.13511612 |
| 39 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.12734153 |
| 40 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.12365514 |
| 41 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.08189479 |
| 42 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.07251818 |
| 43 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.05695048 |
| 44 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.04097376 |
| 45 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.01500839 |
| 46 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.01327479 |
| 47 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.01019887 |
| 48 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.99510902 |
| 49 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.97126901 |
| 50 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.95852805 |
| 51 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.94777299 |
| 52 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.90336053 |
| 53 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.83405509 |
| 54 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.82801101 |
| 55 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.79592378 |
| 56 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.78931776 |
| 57 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.78100091 |
| 58 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.77898173 |
| 59 | P300_19829295_ChIP-Seq_ESCs_Human | 1.76997130 |
| 60 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.71322669 |
| 61 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.71123269 |
| 62 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.68787593 |
| 63 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.68712594 |
| 64 | GATA1_22025678_ChIP-Seq_K562_Human | 1.68186105 |
| 65 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.66259165 |
| 66 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.64495930 |
| 67 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.60419083 |
| 68 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.59156973 |
| 69 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.55732073 |
| 70 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.55114526 |
| 71 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.53787578 |
| 72 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.53426319 |
| 73 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53118068 |
| 74 | MYB_26560356_Chip-Seq_TH2_Human | 1.52926954 |
| 75 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.52805976 |
| 76 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.50405947 |
| 77 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.50147003 |
| 78 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.48565692 |
| 79 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.48496868 |
| 80 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.47278438 |
| 81 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.47168637 |
| 82 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.46898429 |
| 83 | VDR_22108803_ChIP-Seq_LS180_Human | 1.46709321 |
| 84 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.45094149 |
| 85 | MAF_26560356_Chip-Seq_TH1_Human | 1.45021898 |
| 86 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.43786414 |
| 87 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.43393970 |
| 88 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.43356243 |
| 89 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.42613352 |
| 90 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.41376975 |
| 91 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.41310415 |
| 92 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.39794000 |
| 93 | AR_25329375_ChIP-Seq_VCAP_Human | 1.39534636 |
| 94 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.39140172 |
| 95 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.38050955 |
| 96 | FUS_26573619_Chip-Seq_HEK293_Human | 1.36368388 |
| 97 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.34767039 |
| 98 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.34319740 |
| 99 | * FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.32021345 |
| 100 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.31760637 |
| 101 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.29172771 |
| 102 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.29080933 |
| 103 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.28254591 |
| 104 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.23049435 |
| 105 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22822861 |
| 106 | MYB_26560356_Chip-Seq_TH1_Human | 1.22551640 |
| 107 | * PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.21826225 |
| 108 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.21741806 |
| 109 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.21550938 |
| 110 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.20797534 |
| 111 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.20670184 |
| 112 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.20101412 |
| 113 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.19963439 |
| 114 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.16302693 |
| 115 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15970561 |
| 116 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.15175334 |
| 117 | GATA1_19941826_ChIP-Seq_K562_Human | 1.14209392 |
| 118 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.14200556 |
| 119 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.13921116 |
| 120 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.13605029 |
| 121 | STAT3_23295773_ChIP-Seq_U87_Human | 1.13249179 |
| 122 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.12559128 |
| 123 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.11581039 |
| 124 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.11485604 |
| 125 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.11287826 |
| 126 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.10951011 |
| 127 | TCF4_23295773_ChIP-Seq_U87_Human | 1.10916226 |
| 128 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.10027549 |
| 129 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.09219963 |
| 130 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09003161 |
| 131 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08932219 |
| 132 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.08792369 |
| 133 | UTX_26944678_Chip-Seq_JUKART_Human | 1.08216849 |
| 134 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.08185431 |
| 135 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.07439610 |
| 136 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.07283144 |
| 137 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.06874352 |
| 138 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.06338510 |
| 139 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.05344596 |
| 140 | KDM2B_26808549_Chip-Seq_K562_Human | 1.04658584 |
| 141 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.03443802 |
| 142 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.03219851 |
| 143 | * P300_18555785_Chip-Seq_ESCs_Mouse | 1.03090228 |
| 144 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.02736170 |
| 145 | * KDM2B_26808549_Chip-Seq_REH_Human | 1.02333155 |
| 146 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.01439094 |
| 147 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.01063664 |
| 148 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.99910286 |
| 149 | TP53_16413492_ChIP-PET_HCT116_Human | 0.99780636 |
| 150 | * SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.98969812 |
| 151 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.98348737 |
| 152 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.98049611 |
| 153 | GATA2_19941826_ChIP-Seq_K562_Human | 0.97882484 |
| 154 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97794506 |
| 155 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.97526727 |
| 156 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.97262500 |
| 157 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.97249179 |
| 158 | * NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.96802225 |
| 159 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.96712059 |
| 160 | * RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.96269395 |
| 161 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.96040694 |
| 162 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95912883 |
| 163 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.95844517 |
| 164 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94284524 |
| 165 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.94284524 |
| 166 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.94279125 |
| 167 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.93966626 |
| 168 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.93739370 |
| 169 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93437757 |
| 170 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93178787 |
| 171 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91097426 |
| 172 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89693243 |
| 173 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.89510971 |
| 174 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89257368 |
| 175 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.89002233 |
| 176 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88340746 |
| 177 | MYC_22102868_ChIP-Seq_BL_Human | 0.87460815 |
| 178 | MAF_26560356_Chip-Seq_TH2_Human | 0.85658009 |
| 179 | GATA3_26560356_Chip-Seq_TH2_Human | 0.85080877 |
| 180 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.84834112 |
| 181 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.84291587 |
| 182 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.84182880 |
| 183 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.78855021 |
| 184 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.78567688 |
| 185 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.78418660 |
| 186 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.77339247 |
| 187 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.75756482 |
| 188 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.74918153 |
| 189 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.73981121 |
| 190 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.73623245 |
| 191 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.73370993 |
| 192 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.72681971 |
| 193 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.72681971 |
| 194 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.72169136 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 5.34322003 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 4.64200568 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.52255920 |
| 4 | MP0003436_decreased_susceptibility_to | 3.47860056 |
| 5 | MP0009046_muscle_twitch | 3.34052312 |
| 6 | MP0001968_abnormal_touch/_nociception | 3.32198384 |
| 7 | MP0001835_abnormal_antigen_presentation | 3.23656469 |
| 8 | MP0009745_abnormal_behavioral_response | 3.22194765 |
| 9 | MP0001188_hyperpigmentation | 3.16759051 |
| 10 | MP0003136_yellow_coat_color | 3.06831601 |
| 11 | MP0002064_seizures | 2.96368657 |
| 12 | MP0005409_darkened_coat_color | 2.95940577 |
| 13 | MP0004270_analgesia | 2.83685213 |
| 14 | MP0006082_CNS_inflammation | 2.81635694 |
| 15 | MP0002419_abnormal_innate_immunity | 2.81630582 |
| 16 | MP0003300_gastrointestinal_ulcer | 2.80924508 |
| 17 | MP0003690_abnormal_glial_cell | 2.64055198 |
| 18 | MP0002272_abnormal_nervous_system | 2.60760743 |
| 19 | MP0001486_abnormal_startle_reflex | 2.60661183 |
| 20 | MP0002063_abnormal_learning/memory/cond | 2.56543926 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 2.55795774 |
| 22 | MP0009785_altered_susceptibility_to | 2.49319247 |
| 23 | MP0002572_abnormal_emotion/affect_behav | 2.40146763 |
| 24 | MP0005000_abnormal_immune_tolerance | 2.39680879 |
| 25 | MP0002735_abnormal_chemical_nociception | 2.38653450 |
| 26 | MP0002734_abnormal_mechanical_nocicepti | 2.38544998 |
| 27 | MP0005025_abnormal_response_to | 2.36670194 |
| 28 | MP0000569_abnormal_digit_pigmentation | 2.34588497 |
| 29 | MP0002736_abnormal_nociception_after | 2.31184945 |
| 30 | MP0003172_abnormal_lysosome_physiology | 2.29829776 |
| 31 | MP0005423_abnormal_somatic_nervous | 2.27836688 |
| 32 | MP0002148_abnormal_hypersensitivity_rea | 2.27692873 |
| 33 | MP0001800_abnormal_humoral_immune | 2.23286915 |
| 34 | MP0005671_abnormal_response_to | 2.21739030 |
| 35 | MP0009379_abnormal_foot_pigmentation | 2.16197477 |
| 36 | MP0002067_abnormal_sensory_capabilities | 2.12328463 |
| 37 | MP0001790_abnormal_immune_system | 2.11502884 |
| 38 | MP0005387_immune_system_phenotype | 2.11502884 |
| 39 | MP0008260_abnormal_autophagy | 2.10562092 |
| 40 | MP0002452_abnormal_antigen_presenting | 2.10033262 |
| 41 | MP0002723_abnormal_immune_serum | 2.09546684 |
| 42 | MP0003828_pulmonary_edema | 2.09025524 |
| 43 | MP0000685_abnormal_immune_system | 2.07564257 |
| 44 | MP0001533_abnormal_skeleton_physiology | 2.07166986 |
| 45 | MP0001970_abnormal_pain_threshold | 2.06150588 |
| 46 | MP0006276_abnormal_autonomic_nervous | 2.05817101 |
| 47 | MP0001501_abnormal_sleep_pattern | 2.05813962 |
| 48 | MP0005058_abnormal_lysosome_morphology | 1.97453135 |
| 49 | MP0002733_abnormal_thermal_nociception | 1.95755658 |
| 50 | MP0002420_abnormal_adaptive_immunity | 1.93408457 |
| 51 | MP0001819_abnormal_immune_cell | 1.91993846 |
| 52 | MP0001440_abnormal_grooming_behavior | 1.87944573 |
| 53 | MP0005451_abnormal_body_composition | 1.86055048 |
| 54 | MP0005464_abnormal_platelet_physiology | 1.81038680 |
| 55 | MP0004947_skin_inflammation | 1.79491769 |
| 56 | MP0008569_lethality_at_weaning | 1.78583805 |
| 57 | MP0004381_abnormal_hair_follicle | 1.77553530 |
| 58 | MP0000604_amyloidosis | 1.72196296 |
| 59 | MP0004142_abnormal_muscle_tone | 1.71014213 |
| 60 | MP0009764_decreased_sensitivity_to | 1.69393478 |
| 61 | MP0005174_abnormal_tail_pigmentation | 1.68834756 |
| 62 | MP0009278_abnormal_bone_marrow | 1.63132191 |
| 63 | MP0004742_abnormal_vestibular_system | 1.58277574 |
| 64 | MP0002998_abnormal_bone_remodeling | 1.55397941 |
| 65 | MP0002184_abnormal_innervation | 1.54798956 |
| 66 | MP0002557_abnormal_social/conspecific_i | 1.54368653 |
| 67 | MP0002405_respiratory_system_inflammati | 1.53846386 |
| 68 | MP0000015_abnormal_ear_pigmentation | 1.51465037 |
| 69 | MP0003091_abnormal_cell_migration | 1.51188614 |
| 70 | MP0005164_abnormal_response_to | 1.47159438 |
| 71 | MP0005166_decreased_susceptibility_to | 1.46839450 |
| 72 | MP0000858_altered_metastatic_potential | 1.46742441 |
| 73 | MP0001845_abnormal_inflammatory_respons | 1.44806421 |
| 74 | MP0001905_abnormal_dopamine_level | 1.41693936 |
| 75 | MP0000343_altered_response_to | 1.39361371 |
| 76 | MP0002876_abnormal_thyroid_physiology | 1.39259411 |
| 77 | MP0000716_abnormal_immune_system | 1.39149529 |
| 78 | MP0000778_abnormal_nervous_system | 1.38050733 |
| 79 | MP0001986_abnormal_taste_sensitivity | 1.37529229 |
| 80 | MP0002332_abnormal_exercise_endurance | 1.37109449 |
| 81 | MP0001545_abnormal_hematopoietic_system | 1.36271864 |
| 82 | MP0005397_hematopoietic_system_phenotyp | 1.36271864 |
| 83 | MP0003448_altered_tumor_morphology | 1.35773720 |
| 84 | MP0003763_abnormal_thymus_physiology | 1.35770523 |
| 85 | MP0008004_abnormal_stomach_pH | 1.35051533 |
| 86 | MP0003183_abnormal_peptide_metabolism | 1.35036112 |
| 87 | MP0002822_catalepsy | 1.34323561 |
| 88 | MP0002398_abnormal_bone_marrow | 1.32599040 |
| 89 | MP0005167_abnormal_blood-brain_barrier | 1.32461677 |
| 90 | MP0004924_abnormal_behavior | 1.29590221 |
| 91 | MP0005386_behavior/neurological_phenoty | 1.29590221 |
| 92 | MP0003879_abnormal_hair_cell | 1.27714706 |
| 93 | MP0002877_abnormal_melanocyte_morpholog | 1.27106518 |
| 94 | MP0001851_eye_inflammation | 1.26052156 |
| 95 | MP0010155_abnormal_intestine_physiology | 1.25836622 |
| 96 | MP0000465_gastrointestinal_hemorrhage | 1.25213101 |
| 97 | MP0002102_abnormal_ear_morphology | 1.22385123 |
| 98 | MP0001853_heart_inflammation | 1.21867566 |
| 99 | MP0004130_abnormal_muscle_cell | 1.21445426 |
| 100 | MP0006292_abnormal_olfactory_placode | 1.20086540 |
| 101 | MP0000920_abnormal_myelination | 1.18523331 |
| 102 | MP0003656_abnormal_erythrocyte_physiolo | 1.18229579 |
| 103 | MP0002066_abnormal_motor_capabilities/c | 1.18125923 |
| 104 | MP0001984_abnormal_olfaction | 1.16024697 |
| 105 | MP0008469_abnormal_protein_level | 1.14385158 |
| 106 | MP0002882_abnormal_neuron_morphology | 1.13607454 |
| 107 | MP0005645_abnormal_hypothalamus_physiol | 1.12409737 |
| 108 | MP0004811_abnormal_neuron_physiology | 1.10927634 |
| 109 | MP0003329_amyloid_beta_deposits | 1.08280355 |
| 110 | MP0001348_abnormal_lacrimal_gland | 1.07198296 |
| 111 | MP0003633_abnormal_nervous_system | 1.07088348 |
| 112 | MP0003705_abnormal_hypodermis_morpholog | 1.06992087 |
| 113 | MP0004510_myositis | 1.06952904 |
| 114 | MP0008874_decreased_physiological_sensi | 1.06877877 |
| 115 | MP0003453_abnormal_keratinocyte_physiol | 1.06834678 |
| 116 | MP0005551_abnormal_eye_electrophysiolog | 1.05646754 |
| 117 | MP0001529_abnormal_vocalization | 1.03980187 |
| 118 | MP0002722_abnormal_immune_system | 1.03203948 |
| 119 | MP0001958_emphysema | 1.03167901 |
| 120 | MP0003303_peritoneal_inflammation | 1.02090035 |
| 121 | MP0000689_abnormal_spleen_morphology | 1.01817343 |
| 122 | MP0001502_abnormal_circadian_rhythm | 1.01476720 |
| 123 | MP0003866_abnormal_defecation | 1.01198587 |
| 124 | MP0000955_abnormal_spinal_cord | 1.01085011 |
| 125 | MP0002429_abnormal_blood_cell | 1.00992071 |
| 126 | MP0002254_reproductive_system_inflammat | 1.00156082 |
| 127 | MP0005646_abnormal_pituitary_gland | 0.99925362 |
| 128 | MP0001963_abnormal_hearing_physiology | 0.98905366 |
| 129 | MP0004484_altered_response_of | 0.96211873 |
| 130 | MP0003045_fibrosis | 0.94211158 |
| 131 | MP0002229_neurodegeneration | 0.93306420 |
| 132 | MP0002277_abnormal_respiratory_mucosa | 0.93266087 |
| 133 | MP0004885_abnormal_endolymph | 0.91561365 |
| 134 | MP0005310_abnormal_salivary_gland | 0.89807981 |
| 135 | MP0008872_abnormal_physiological_respon | 0.89664020 |
| 136 | MP0002166_altered_tumor_susceptibility | 0.88797887 |
| 137 | MP0002095_abnormal_skin_pigmentation | 0.86320991 |
| 138 | MP0003631_nervous_system_phenotype | 0.85875611 |
| 139 | MP0002638_abnormal_pupillary_reflex | 0.85754593 |
| 140 | MP0004808_abnormal_hematopoietic_stem | 0.85415858 |
| 141 | MP0005379_endocrine/exocrine_gland_phen | 0.84637861 |
| 142 | MP0004145_abnormal_muscle_electrophysio | 0.81724426 |
| 143 | MP0005390_skeleton_phenotype | 0.80412039 |
| 144 | MP0000249_abnormal_blood_vessel | 0.80200295 |
| 145 | MP0005535_abnormal_body_temperature | 0.79244355 |
| 146 | MP0009333_abnormal_splenocyte_physiolog | 0.79161351 |
| 147 | MP0001346_abnormal_lacrimal_gland | 0.79005251 |
| 148 | MP0003566_abnormal_cell_adhesion | 0.78572694 |
| 149 | MP0005388_respiratory_system_phenotype | 0.78326814 |
| 150 | MP0002133_abnormal_respiratory_system | 0.78326814 |
| 151 | MP0002163_abnormal_gland_morphology | 0.78281866 |
| 152 | MP0003787_abnormal_imprinting | 0.77433433 |
| 153 | MP0000703_abnormal_thymus_morphology | 0.76876393 |
| 154 | MP0002752_abnormal_somatic_nervous | 0.76636256 |
| 155 | MP0002152_abnormal_brain_morphology | 0.75494061 |
| 156 | MP0003724_increased_susceptibility_to | 0.74306182 |
| 157 | MP0003221_abnormal_cardiomyocyte_apopto | 0.74004187 |
| 158 | MP0005595_abnormal_vascular_smooth | 0.73932770 |
| 159 | MP0006054_spinal_hemorrhage | 0.73351458 |
| 160 | MP0005076_abnormal_cell_differentiation | 0.73147345 |
| 161 | MP0002006_tumorigenesis | 0.72767372 |
| 162 | MP0002132_abnormal_respiratory_system | 0.72750682 |
| 163 | MP0000026_abnormal_inner_ear | 0.72566859 |
| 164 | MP0001664_abnormal_digestion | 0.71897002 |
| 165 | MP0009763_increased_sensitivity_to | 0.71631892 |
| 166 | MP0001485_abnormal_pinna_reflex | 0.70892822 |
| 167 | MP0001177_atelectasis | 0.70257718 |
| 168 | MP0009840_abnormal_foam_cell | 0.69649153 |
| 169 | MP0002009_preneoplasia | 0.68553360 |
| 170 | MP0010352_gastrointestinal_tract_polyps | 0.68488991 |
| 171 | MP0002396_abnormal_hematopoietic_system | 0.68440942 |
| 172 | MP0005171_absent_coat_pigmentation | 0.67908627 |
| 173 | MP0010386_abnormal_urinary_bladder | 0.67452322 |
| 174 | MP0003938_abnormal_ear_development | 0.64564330 |
| 175 | MP0002909_abnormal_adrenal_gland | 0.61836785 |
| 176 | MP0002069_abnormal_eating/drinking_beha | 0.60716916 |
| 177 | MP0004147_increased_porphyrin_level | 0.59222739 |
| 178 | MP0000631_abnormal_neuroendocrine_gland | 0.58375987 |
| 179 | MP0003632_abnormal_nervous_system | 0.56310585 |
| 180 | MP0004883_abnormal_blood_vessel | 0.56255890 |
| 181 | MP0002138_abnormal_hepatobiliary_system | 0.56085120 |
| 182 | MP0003075_altered_response_to | 0.53727830 |
| 183 | MP0004858_abnormal_nervous_system | 0.53506408 |
| 184 | MP0003634_abnormal_glial_cell | 0.52928680 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.65370005 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.43308331 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.38046966 |
| 4 | Focal seizures (HP:0007359) | 5.09541293 |
| 5 | Febrile seizures (HP:0002373) | 5.05596652 |
| 6 | Recurrent abscess formation (HP:0002722) | 5.05156797 |
| 7 | Atonic seizures (HP:0010819) | 4.86415955 |
| 8 | Orchitis (HP:0100796) | 4.85807189 |
| 9 | Myokymia (HP:0002411) | 4.73953920 |
| 10 | Optic neuritis (HP:0100653) | 4.71835221 |
| 11 | Retrobulbar optic neuritis (HP:0100654) | 4.71835221 |
| 12 | Myositis (HP:0100614) | 4.65836332 |
| 13 | Abnormality of macrophages (HP:0004311) | 4.41674180 |
| 14 | Epileptic encephalopathy (HP:0200134) | 4.35060644 |
| 15 | Visual hallucinations (HP:0002367) | 4.24161579 |
| 16 | Progressive cerebellar ataxia (HP:0002073) | 4.07819883 |
| 17 | Absence seizures (HP:0002121) | 3.95991083 |
| 18 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.90099126 |
| 19 | Dialeptic seizures (HP:0011146) | 3.81692105 |
| 20 | Gaze-evoked nystagmus (HP:0000640) | 3.70384749 |
| 21 | Broad-based gait (HP:0002136) | 3.69083523 |
| 22 | Hyperventilation (HP:0002883) | 3.63701566 |
| 23 | Abnormality of secondary sexual hair (HP:0009888) | 3.59523772 |
| 24 | Abnormality of the axillary hair (HP:0100134) | 3.59523772 |
| 25 | Progressive inability to walk (HP:0002505) | 3.51129938 |
| 26 | Keratoconjunctivitis sicca (HP:0001097) | 3.49650856 |
| 27 | Generalized tonic-clonic seizures (HP:0002069) | 3.47386501 |
| 28 | Mediastinal lymphadenopathy (HP:0100721) | 3.47276117 |
| 29 | Stomatitis (HP:0010280) | 3.43092457 |
| 30 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.42656140 |
| 31 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.42656140 |
| 32 | Abnormality of glycolipid metabolism (HP:0010969) | 3.42656140 |
| 33 | Recurrent skin infections (HP:0001581) | 3.36712388 |
| 34 | Gingivitis (HP:0000230) | 3.30921649 |
| 35 | Recurrent fungal infections (HP:0002841) | 3.23696821 |
| 36 | Absent speech (HP:0001344) | 3.22235557 |
| 37 | Gastrointestinal infarctions (HP:0005244) | 3.21058570 |
| 38 | Amyloidosis (HP:0011034) | 3.18284648 |
| 39 | Spontaneous hematomas (HP:0007420) | 3.17788333 |
| 40 | Keratoconjunctivitis (HP:0001096) | 3.14529802 |
| 41 | T lymphocytopenia (HP:0005403) | 3.10183086 |
| 42 | Action tremor (HP:0002345) | 3.08687838 |
| 43 | Obstructive sleep apnea (HP:0002870) | 3.06221811 |
| 44 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.94359573 |
| 45 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.92066853 |
| 46 | Absent/shortened dynein arms (HP:0200106) | 2.92066853 |
| 47 | Abnormal sex determination (HP:0012244) | 2.90146142 |
| 48 | Sex reversal (HP:0012245) | 2.90146142 |
| 49 | Dysmetria (HP:0001310) | 2.90095834 |
| 50 | Scanning speech (HP:0002168) | 2.84537492 |
| 51 | Abnormality of T cell number (HP:0011839) | 2.82198276 |
| 52 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.81689565 |
| 53 | Meningitis (HP:0001287) | 2.78563411 |
| 54 | Increased cerebral lipofuscin (HP:0011813) | 2.78157380 |
| 55 | Peritonitis (HP:0002586) | 2.77223569 |
| 56 | Inability to walk (HP:0002540) | 2.74979306 |
| 57 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.74836455 |
| 58 | Arterial thrombosis (HP:0004420) | 2.73638435 |
| 59 | Dysdiadochokinesis (HP:0002075) | 2.72489129 |
| 60 | Cellulitis (HP:0100658) | 2.71733925 |
| 61 | Hemoptysis (HP:0002105) | 2.63960775 |
| 62 | Vasculitis (HP:0002633) | 2.61221249 |
| 63 | Pulmonary infiltrates (HP:0002113) | 2.60752432 |
| 64 | Disinhibition (HP:0000734) | 2.58899718 |
| 65 | Amblyopia (HP:0000646) | 2.55975665 |
| 66 | Truncal ataxia (HP:0002078) | 2.55781211 |
| 67 | Loss of speech (HP:0002371) | 2.52786901 |
| 68 | Poor eye contact (HP:0000817) | 2.49492871 |
| 69 | Gingival bleeding (HP:0000225) | 2.49484922 |
| 70 | Supranuclear gaze palsy (HP:0000605) | 2.49266055 |
| 71 | Urticaria (HP:0001025) | 2.48273723 |
| 72 | Chest pain (HP:0100749) | 2.48122154 |
| 73 | Hemiparesis (HP:0001269) | 2.47465222 |
| 74 | Encephalitis (HP:0002383) | 2.45786545 |
| 75 | Abnormal ciliary motility (HP:0012262) | 2.45362703 |
| 76 | Dysostosis multiplex (HP:0000943) | 2.41741518 |
| 77 | Episodic fever (HP:0001954) | 2.39467568 |
| 78 | Excessive salivation (HP:0003781) | 2.38923296 |
| 79 | Drooling (HP:0002307) | 2.38923296 |
| 80 | Diplopia (HP:0000651) | 2.37660424 |
| 81 | Abnormality of binocular vision (HP:0011514) | 2.37660424 |
| 82 | Slow saccadic eye movements (HP:0000514) | 2.37186339 |
| 83 | Increased IgE level (HP:0003212) | 2.36099103 |
| 84 | Mutism (HP:0002300) | 2.35185569 |
| 85 | Fair hair (HP:0002286) | 2.31166568 |
| 86 | Esotropia (HP:0000565) | 2.30229298 |
| 87 | Generalized myoclonic seizures (HP:0002123) | 2.29824544 |
| 88 | Agammaglobulinemia (HP:0004432) | 2.29122124 |
| 89 | Recurrent viral infections (HP:0004429) | 2.27878026 |
| 90 | Pulmonary embolism (HP:0002204) | 2.27650309 |
| 91 | Subacute progressive viral hepatitis (HP:0006572) | 2.26870588 |
| 92 | Anxiety (HP:0000739) | 2.26018017 |
| 93 | Peripheral hypomyelination (HP:0007182) | 2.24461811 |
| 94 | Abnormal social behavior (HP:0012433) | 2.23945774 |
| 95 | Impaired social interactions (HP:0000735) | 2.23945774 |
| 96 | Sleep apnea (HP:0010535) | 2.23803372 |
| 97 | Genetic anticipation (HP:0003743) | 2.20116735 |
| 98 | Vertigo (HP:0002321) | 2.18155597 |
| 99 | Epistaxis (HP:0000421) | 2.18145446 |
| 100 | Leukocytosis (HP:0001974) | 2.17536269 |
| 101 | Optic disc pallor (HP:0000543) | 2.16902718 |
| 102 | Gangrene (HP:0100758) | 2.15473642 |
| 103 | Interstitial pulmonary disease (HP:0006530) | 2.14974883 |
| 104 | Generalized hypopigmentation of hair (HP:0011358) | 2.14801282 |
| 105 | Neurofibrillary tangles (HP:0002185) | 2.14701896 |
| 106 | Neuronal loss in central nervous system (HP:0002529) | 2.13048087 |
| 107 | Nonprogressive disorder (HP:0003680) | 2.12101896 |
| 108 | Papilledema (HP:0001085) | 2.12065888 |
| 109 | Prolonged bleeding time (HP:0003010) | 2.11709772 |
| 110 | Abnormal eating behavior (HP:0100738) | 2.11214168 |
| 111 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.11057422 |
| 112 | Hemiplegia (HP:0002301) | 2.10592675 |
| 113 | Osteomyelitis (HP:0002754) | 2.09735130 |
| 114 | Abnormality of the endocardium (HP:0004306) | 2.09292500 |
| 115 | Retinal dysplasia (HP:0007973) | 2.08856716 |
| 116 | Depression (HP:0000716) | 2.08850231 |
| 117 | Postural instability (HP:0002172) | 2.07802967 |
| 118 | Status epilepticus (HP:0002133) | 2.07350321 |
| 119 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.04611410 |
| 120 | Abnormal biliary tract physiology (HP:0012439) | 2.03054813 |
| 121 | Bile duct proliferation (HP:0001408) | 2.03054813 |
| 122 | Iris hypopigmentation (HP:0007730) | 2.03048584 |
| 123 | Myocardial infarction (HP:0001658) | 2.02102746 |
| 124 | Split foot (HP:0001839) | 1.99472020 |
| 125 | Stereotypic behavior (HP:0000733) | 1.98771630 |
| 126 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.97089363 |
| 127 | Blue irides (HP:0000635) | 1.95236427 |
| 128 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.92891038 |
| 129 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.92891038 |
| 130 | Anorexia (HP:0002039) | 1.92607964 |
| 131 | Protruding tongue (HP:0010808) | 1.91963712 |
| 132 | Systemic lupus erythematosus (HP:0002725) | 1.91058137 |
| 133 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.90117214 |
| 134 | Apathy (HP:0000741) | 1.89186222 |
| 135 | Ocular albinism (HP:0001107) | 1.89124492 |
| 136 | Abnormality of salivation (HP:0100755) | 1.88159129 |
| 137 | Thickened helices (HP:0000391) | 1.87830093 |
| 138 | Abnormality of the peritoneum (HP:0002585) | 1.87581611 |
| 139 | Thyroid-stimulating hormone excess (HP:0002925) | 1.87156532 |
| 140 | Glomerulopathy (HP:0100820) | 1.86981824 |
| 141 | Autoimmune thrombocytopenia (HP:0001973) | 1.86933688 |
| 142 | Inflammation of the large intestine (HP:0002037) | 1.86519814 |
| 143 | Impaired smooth pursuit (HP:0007772) | 1.84617431 |
| 144 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.84369322 |
| 145 | Mucopolysacchariduria (HP:0008155) | 1.84369322 |
| 146 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.84286125 |
| 147 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.84286125 |
| 148 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.84286125 |
| 149 | Sepsis (HP:0100806) | 1.83838045 |
| 150 | Cerebral inclusion bodies (HP:0100314) | 1.83450401 |
| 151 | Increased CSF protein (HP:0002922) | 1.83301677 |
| 152 | Abnormality of the pleura (HP:0002103) | 1.83142413 |
| 153 | Viral hepatitis (HP:0006562) | 1.82644453 |
| 154 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.81395592 |
| 155 | Ulnar claw (HP:0001178) | 1.81327850 |
| 156 | Colitis (HP:0002583) | 1.81216630 |
| 157 | Chronic obstructive pulmonary disease (HP:0006510) | 1.80745331 |
| 158 | Obstructive lung disease (HP:0006536) | 1.80745331 |
| 159 | Hyperthyroidism (HP:0000836) | 1.80615685 |
| 160 | Diminished motivation (HP:0000745) | 1.80033992 |
| 161 | Difficulty running (HP:0009046) | 1.79100513 |
| 162 | Attenuation of retinal blood vessels (HP:0007843) | 1.78832874 |
| 163 | Hypothermia (HP:0002045) | 1.78647703 |
| 164 | Limb dystonia (HP:0002451) | 1.77869854 |
| 165 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.77867203 |
| 166 | Psychosis (HP:0000709) | 1.77501633 |
| 167 | Sensory axonal neuropathy (HP:0003390) | 1.77121130 |
| 168 | Hematochezia (HP:0002573) | 1.75590807 |
| 169 | Gastrointestinal inflammation (HP:0004386) | 1.75578115 |
| 170 | Alacrima (HP:0000522) | 1.75460775 |
| 171 | Fetal akinesia sequence (HP:0001989) | 1.75226468 |
| 172 | Periodontitis (HP:0000704) | 1.75045309 |
| 173 | Memory impairment (HP:0002354) | 1.74023780 |
| 174 | Widely spaced teeth (HP:0000687) | 1.73190827 |
| 175 | Testicular neoplasm (HP:0010788) | 1.72587602 |
| 176 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.71839323 |
| 177 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.70524742 |
| 178 | Rapidly progressive (HP:0003678) | 1.69388215 |
| 179 | Vacuolated lymphocytes (HP:0001922) | 1.68980957 |
| 180 | Optic nerve hypoplasia (HP:0000609) | 1.67646206 |
| 181 | Parakeratosis (HP:0001036) | 1.66868770 |
| 182 | Polyphagia (HP:0002591) | 1.66408144 |
| 183 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.65726114 |
| 184 | Clumsiness (HP:0002312) | 1.64542443 |
| 185 | Intention tremor (HP:0002080) | 1.63503258 |
| 186 | Horizontal nystagmus (HP:0000666) | 1.60528936 |
| 187 | Inappropriate behavior (HP:0000719) | 1.59996886 |
| 188 | Recurrent cutaneous fungal infections (HP:0011370) | 1.59807012 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 6.11416989 |
| 2 | NTRK3 | 3.54503845 |
| 3 | RIPK4 | 3.09841640 |
| 4 | TNIK | 3.04181575 |
| 5 | EPHA4 | 2.79839550 |
| 6 | MAP3K12 | 2.77072530 |
| 7 | MKNK2 | 2.65913317 |
| 8 | FES | 2.65528286 |
| 9 | MAP2K3 | 2.60967361 |
| 10 | TYK2 | 2.56331798 |
| 11 | MAP2K7 | 2.51056078 |
| 12 | CSK | 2.38244163 |
| 13 | CDK19 | 2.10990376 |
| 14 | PNCK | 1.93737335 |
| 15 | MAP3K9 | 1.90187073 |
| 16 | MAP3K4 | 1.88613032 |
| 17 | MAP3K13 | 1.87553162 |
| 18 | JAK1 | 1.82843367 |
| 19 | ZAP70 | 1.75610552 |
| 20 | MINK1 | 1.70953944 |
| 21 | JAK3 | 1.69184172 |
| 22 | ERN1 | 1.69129274 |
| 23 | RIPK1 | 1.67876563 |
| 24 | MAP2K4 | 1.66743979 |
| 25 | MAP4K1 | 1.63777370 |
| 26 | MAP3K3 | 1.61173834 |
| 27 | MUSK | 1.57907396 |
| 28 | EPHB1 | 1.57170805 |
| 29 | JAK2 | 1.55628332 |
| 30 | GRK5 | 1.51286248 |
| 31 | TGFBR2 | 1.49451518 |
| 32 | PHKG1 | 1.43955067 |
| 33 | PHKG2 | 1.43955067 |
| 34 | IKBKE | 1.43353231 |
| 35 | BMPR2 | 1.42314783 |
| 36 | IRAK3 | 1.34623637 |
| 37 | DAPK2 | 1.33524478 |
| 38 | BLK | 1.32767261 |
| 39 | HCK | 1.31467939 |
| 40 | FGR | 1.30107864 |
| 41 | MAP3K1 | 1.28246033 |
| 42 | SIK2 | 1.26914117 |
| 43 | TBK1 | 1.25383645 |
| 44 | MAPK13 | 1.23383579 |
| 45 | MOS | 1.23149147 |
| 46 | TAOK1 | 1.19864647 |
| 47 | CAMKK2 | 1.18692774 |
| 48 | BTK | 1.18472730 |
| 49 | SGK3 | 1.16837572 |
| 50 | OXSR1 | 1.16353599 |
| 51 | CDK5 | 1.10592515 |
| 52 | MAP3K11 | 1.08708701 |
| 53 | TXK | 1.08474851 |
| 54 | TLK1 | 1.07789074 |
| 55 | NTRK1 | 1.07197709 |
| 56 | ARAF | 1.05616232 |
| 57 | CAMK2A | 1.04759337 |
| 58 | CSF1R | 1.04463080 |
| 59 | CAMK2B | 1.03807635 |
| 60 | PRPF4B | 1.02847519 |
| 61 | MKNK1 | 1.02469832 |
| 62 | TAOK2 | 1.00716239 |
| 63 | MARK2 | 1.00095659 |
| 64 | LYN | 0.99159280 |
| 65 | GRK7 | 0.98922611 |
| 66 | PLK2 | 0.98312105 |
| 67 | NTRK2 | 0.98055107 |
| 68 | CAMK1 | 0.96690849 |
| 69 | TNK2 | 0.96339509 |
| 70 | PKN1 | 0.94185173 |
| 71 | DYRK1A | 0.93286637 |
| 72 | STK39 | 0.92269343 |
| 73 | KSR1 | 0.90351060 |
| 74 | STK11 | 0.89914907 |
| 75 | PAK6 | 0.88860161 |
| 76 | DAPK1 | 0.88677839 |
| 77 | TRIB3 | 0.88216703 |
| 78 | MARK1 | 0.87339189 |
| 79 | UHMK1 | 0.87115849 |
| 80 | MAPKAPK5 | 0.87068494 |
| 81 | FGFR3 | 0.85721488 |
| 82 | PIK3CG | 0.83378409 |
| 83 | LCK | 0.80193053 |
| 84 | STK38 | 0.77067733 |
| 85 | CAMKK1 | 0.76252864 |
| 86 | IRAK4 | 0.75064520 |
| 87 | MAP3K5 | 0.74599449 |
| 88 | NME1 | 0.74548092 |
| 89 | FER | 0.74354142 |
| 90 | WNK1 | 0.74244838 |
| 91 | ADRBK2 | 0.73811983 |
| 92 | INSRR | 0.72826748 |
| 93 | PDGFRB | 0.72344419 |
| 94 | RET | 0.71745773 |
| 95 | KSR2 | 0.70866256 |
| 96 | PRKCG | 0.70052538 |
| 97 | STK10 | 0.69214302 |
| 98 | CDK6 | 0.68677686 |
| 99 | MARK3 | 0.68574391 |
| 100 | CDC42BPA | 0.68491867 |
| 101 | PRKCE | 0.68084598 |
| 102 | MAP3K14 | 0.67688911 |
| 103 | PTK2B | 0.67503900 |
| 104 | MAPK7 | 0.65120474 |
| 105 | KIT | 0.64783090 |
| 106 | STK16 | 0.62463807 |
| 107 | IKBKB | 0.61612686 |
| 108 | CAMK2D | 0.61325848 |
| 109 | LRRK2 | 0.60862715 |
| 110 | NEK9 | 0.60785017 |
| 111 | MAP3K6 | 0.60516957 |
| 112 | SIK3 | 0.60181150 |
| 113 | ITK | 0.60172174 |
| 114 | IRAK2 | 0.59932578 |
| 115 | TEC | 0.57541132 |
| 116 | PRKD2 | 0.56624246 |
| 117 | SGK1 | 0.56497168 |
| 118 | SYK | 0.55126799 |
| 119 | RAF1 | 0.54047113 |
| 120 | IRAK1 | 0.53808667 |
| 121 | NEK6 | 0.53808186 |
| 122 | TTN | 0.53403267 |
| 123 | BMPR1B | 0.52672368 |
| 124 | CAMK2G | 0.50813488 |
| 125 | HIPK2 | 0.49922668 |
| 126 | CAMK1G | 0.49349271 |
| 127 | PTK6 | 0.47232530 |
| 128 | PRKG1 | 0.45857877 |
| 129 | YES1 | 0.45764007 |
| 130 | TAOK3 | 0.45634170 |
| 131 | CDK3 | 0.45359637 |
| 132 | TRPM7 | 0.45201925 |
| 133 | PRKCQ | 0.43636060 |
| 134 | SGK223 | 0.42850558 |
| 135 | SGK494 | 0.42850558 |
| 136 | ROCK2 | 0.42791649 |
| 137 | PRKAA2 | 0.41662998 |
| 138 | FYN | 0.41244758 |
| 139 | MATK | 0.40747449 |
| 140 | MAPK12 | 0.39653834 |
| 141 | GRK6 | 0.39495188 |
| 142 | PDK1 | 0.39387544 |
| 143 | DYRK1B | 0.38928849 |
| 144 | CLK1 | 0.38277340 |
| 145 | PDPK1 | 0.38173944 |
| 146 | SGK2 | 0.38148960 |
| 147 | MAP3K2 | 0.38112481 |
| 148 | CDK14 | 0.37824462 |
| 149 | CSNK1G2 | 0.37568820 |
| 150 | PRKACA | 0.36889880 |
| 151 | BCR | 0.36303806 |
| 152 | CAMK4 | 0.34049444 |
| 153 | RPS6KL1 | 0.33519510 |
| 154 | RPS6KC1 | 0.33519510 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.26586795 |
| 2 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.93655218 |
| 3 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.70510732 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.66750831 |
| 5 | Morphine addiction_Homo sapiens_hsa05032 | 2.66087013 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.53877233 |
| 7 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.50373417 |
| 8 | Long-term potentiation_Homo sapiens_hsa04720 | 2.41044997 |
| 9 | Circadian entrainment_Homo sapiens_hsa04713 | 2.33534646 |
| 10 | Taste transduction_Homo sapiens_hsa04742 | 2.29089454 |
| 11 | Olfactory transduction_Homo sapiens_hsa04740 | 2.21185290 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.19037691 |
| 13 | Long-term depression_Homo sapiens_hsa04730 | 2.17933281 |
| 14 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.14700817 |
| 15 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.06604325 |
| 16 | Serotonergic synapse_Homo sapiens_hsa04726 | 2.06225286 |
| 17 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.05413144 |
| 18 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.80156936 |
| 19 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.78792307 |
| 20 | Malaria_Homo sapiens_hsa05144 | 1.77304500 |
| 21 | Phototransduction_Homo sapiens_hsa04744 | 1.74431512 |
| 22 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.74020232 |
| 23 | Renin secretion_Homo sapiens_hsa04924 | 1.72596966 |
| 24 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.71919669 |
| 25 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.65272313 |
| 26 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.64733735 |
| 27 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.64330969 |
| 28 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.64240499 |
| 29 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.55606221 |
| 30 | Legionellosis_Homo sapiens_hsa05134 | 1.54479559 |
| 31 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.47368195 |
| 32 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.46506683 |
| 33 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.45002893 |
| 34 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.43861214 |
| 35 | Insulin secretion_Homo sapiens_hsa04911 | 1.42135319 |
| 36 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.41883659 |
| 37 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.38662783 |
| 38 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.38252477 |
| 39 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.36287645 |
| 40 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.36120311 |
| 41 | Measles_Homo sapiens_hsa05162 | 1.32586100 |
| 42 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.31636668 |
| 43 | Influenza A_Homo sapiens_hsa05164 | 1.30639560 |
| 44 | Phagosome_Homo sapiens_hsa04145 | 1.28742178 |
| 45 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.26603066 |
| 46 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.26326029 |
| 47 | Pertussis_Homo sapiens_hsa05133 | 1.23554060 |
| 48 | Other glycan degradation_Homo sapiens_hsa00511 | 1.22643303 |
| 49 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.22571410 |
| 50 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.21836742 |
| 51 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.21404712 |
| 52 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.20842686 |
| 53 | Cocaine addiction_Homo sapiens_hsa05030 | 1.20097372 |
| 54 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.18597028 |
| 55 | Salmonella infection_Homo sapiens_hsa05132 | 1.17861381 |
| 56 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.15073636 |
| 57 | Lysosome_Homo sapiens_hsa04142 | 1.14781732 |
| 58 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.14325387 |
| 59 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.11857864 |
| 60 | Alzheimers disease_Homo sapiens_hsa05010 | 1.10197608 |
| 61 | Hepatitis B_Homo sapiens_hsa05161 | 1.10014716 |
| 62 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.09398946 |
| 63 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.08729503 |
| 64 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.07754658 |
| 65 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.07328448 |
| 66 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.06760719 |
| 67 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.06737795 |
| 68 | Axon guidance_Homo sapiens_hsa04360 | 1.06692022 |
| 69 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.05355897 |
| 70 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.02097845 |
| 71 | Hepatitis C_Homo sapiens_hsa05160 | 0.99898431 |
| 72 | Melanogenesis_Homo sapiens_hsa04916 | 0.99604606 |
| 73 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.99588956 |
| 74 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.99291775 |
| 75 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.99214766 |
| 76 | Amoebiasis_Homo sapiens_hsa05146 | 0.98989209 |
| 77 | Gap junction_Homo sapiens_hsa04540 | 0.98030274 |
| 78 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.97362582 |
| 79 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.96957220 |
| 80 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.93293556 |
| 81 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.91488916 |
| 82 | Viral myocarditis_Homo sapiens_hsa05416 | 0.89169186 |
| 83 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.88350088 |
| 84 | Apoptosis_Homo sapiens_hsa04210 | 0.87970209 |
| 85 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.87665641 |
| 86 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.87544676 |
| 87 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.84660617 |
| 88 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.84257581 |
| 89 | Shigellosis_Homo sapiens_hsa05131 | 0.82898638 |
| 90 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.82527439 |
| 91 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.82391253 |
| 92 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.82257460 |
| 93 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.80527187 |
| 94 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.80320535 |
| 95 | Endometrial cancer_Homo sapiens_hsa05213 | 0.79461183 |
| 96 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.78076554 |
| 97 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.76838815 |
| 98 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.76755895 |
| 99 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.76400998 |
| 100 | Endocytosis_Homo sapiens_hsa04144 | 0.75920014 |
| 101 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.75633745 |
| 102 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.75067732 |
| 103 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.74811513 |
| 104 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.74137566 |
| 105 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.72609629 |
| 106 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.72143122 |
| 107 | Parkinsons disease_Homo sapiens_hsa05012 | 0.71962765 |
| 108 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.70371713 |
| 109 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.70192947 |
| 110 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.67837390 |
| 111 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.67226009 |
| 112 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.67037890 |
| 113 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.66672468 |
| 114 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.65518193 |
| 115 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.65469119 |
| 116 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.64886787 |
| 117 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.63411311 |
| 118 | Glioma_Homo sapiens_hsa05214 | 0.63375591 |
| 119 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.62954564 |
| 120 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.60063769 |
| 121 | Prion diseases_Homo sapiens_hsa05020 | 0.59814600 |
| 122 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.58421236 |
| 123 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.57619034 |
| 124 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.57331095 |
| 125 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.54279388 |
| 126 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.52852463 |
| 127 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.51473001 |
| 128 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.50385883 |
| 129 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.49918084 |
| 130 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.48628668 |
| 131 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.46597576 |
| 132 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.45524314 |
| 133 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.43768965 |
| 134 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.43539624 |
| 135 | Huntingtons disease_Homo sapiens_hsa05016 | 0.43228434 |
| 136 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.40949771 |
| 137 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.40821523 |
| 138 | Allograft rejection_Homo sapiens_hsa05330 | 0.40250173 |
| 139 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.40126677 |
| 140 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.40054089 |
| 141 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.39987814 |
| 142 | Asthma_Homo sapiens_hsa05310 | 0.39587399 |
| 143 | Platelet activation_Homo sapiens_hsa04611 | 0.38240401 |
| 144 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.37379251 |
| 145 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.36121694 |
| 146 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.34267547 |
| 147 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.33819912 |
| 148 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.33554240 |
| 149 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.33314025 |
| 150 | Circadian rhythm_Homo sapiens_hsa04710 | 0.33007271 |
| 151 | Tuberculosis_Homo sapiens_hsa05152 | 0.31728223 |
| 152 | Alcoholism_Homo sapiens_hsa05034 | 0.30812484 |
| 153 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.29226222 |
| 154 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.28825636 |
| 155 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.27524204 |
| 156 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.25830774 |

